Log in
(Ad)
Located just 25 miles from Cleveland... is a supergreenhouse unlike anything we've ever seen. Listed at over 1.4 million sq ft, (the size of 9 full-sized Costco warehouses), this marijuana grow house is capable of producing over 341,000 pounds of weed/year! And very soon it will come online and could turn a tiny 60-cent pot company into the dominator in the white-hot weed market.

NASDAQ:NYMX - Nymox Pharmaceutical Stock Price, Forecast & News

$2.98
-0.13 (-4.18 %)
(As of 01/24/2020 01:43 AM ET)
Today's Range
$2.97
Now: $2.98
$3.10
50-Day Range
$1.85
MA: $2.53
$3.24
52-Week Range
$1.32
Now: $2.98
$3.28
Volume108,800 shs
Average Volume265,053 shs
Market Capitalization$208.51 million
P/E RatioN/A
Dividend YieldN/A
Beta1.91
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NYMX
CUSIPN/A
Phone800-936-9669

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$300,000.00
Book Value$0.12 per share

Profitability

Net Income$-10,590,000.00
Net Margins-12,217.59%

Miscellaneous

EmployeesN/A
Market Cap$208.51 million
Next Earnings Date4/3/2020 (Estimated)
OptionableOptionable

Receive NYMX News and Ratings via Email

Sign-up to receive the latest news and ratings for NYMX and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%?

Wall Street legend Paul Mampilly recently identified this as the stock of the century.

Buying up a handful of shares of this small company now could change your life and even make you millions.

Nymox Pharmaceutical (NASDAQ:NYMX) Frequently Asked Questions

What is Nymox Pharmaceutical's stock symbol?

Nymox Pharmaceutical trades on the NASDAQ under the ticker symbol "NYMX."

How were Nymox Pharmaceutical's earnings last quarter?

Nymox Pharmaceutical Corp (NASDAQ:NYMX) posted its earnings results on Wednesday, November, 13th. The biopharmaceutical company reported ($0.04) earnings per share for the quarter. The biopharmaceutical company earned $0.04 million during the quarter. Nymox Pharmaceutical had a negative net margin of 12,217.59% and a negative return on equity of 174.16%. View Nymox Pharmaceutical's Earnings History.

When is Nymox Pharmaceutical's next earnings date?

Nymox Pharmaceutical is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Nymox Pharmaceutical.

Has Nymox Pharmaceutical been receiving favorable news coverage?

Media coverage about NYMX stock has trended somewhat positive recently, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nymox Pharmaceutical earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Nymox Pharmaceutical.

Who are some of Nymox Pharmaceutical's key competitors?

What other stocks do shareholders of Nymox Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nymox Pharmaceutical investors own include Quantum (QTM), Rocket Pharmaceuticals (RCKT), NovaBay Pharmaceuticals (NBY), Synergy Pharmaceuticals (SGYP), Biocept (BIOC), TherapeuticsMD (TXMD), Catalyst Pharmaceuticals (CPRX), MEI Pharma (MEIP), Rigel Pharmaceuticals (RIGL) and CTI BioPharma (CTIC).

Who are Nymox Pharmaceutical's key executives?

Nymox Pharmaceutical's management team includes the folowing people:
  • Dr. Paul Averback, Founder, Chairman, CEO & Pres (Age 68)
  • Mr. Erik Danielsen, Chief Financial Officer (Age 56)
  • Mr. Randall J. Lanham, Gen. Counsel, Sec. & Director (Age 55)

Who are Nymox Pharmaceutical's major shareholders?

Nymox Pharmaceutical's stock is owned by many different of retail and institutional investors. Top institutional investors include Wedbush Securities Inc. (0.06%) and Patriot Financial Group Insurance Agency LLC (0.05%). Company insiders that own Nymox Pharmaceutical stock include Erik Danielsen, James George Robinson, Paul Averback and Randall J Lanham. View Institutional Ownership Trends for Nymox Pharmaceutical.

Which major investors are selling Nymox Pharmaceutical stock?

NYMX stock was sold by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for Nymox Pharmaceutical.

Which major investors are buying Nymox Pharmaceutical stock?

NYMX stock was bought by a variety of institutional investors in the last quarter, including Patriot Financial Group Insurance Agency LLC. Company insiders that have bought Nymox Pharmaceutical stock in the last two years include Erik Danielsen, James George Robinson and Randall J Lanham. View Insider Buying and Selling for Nymox Pharmaceutical.

How do I buy shares of Nymox Pharmaceutical?

Shares of NYMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nymox Pharmaceutical's stock price today?

One share of NYMX stock can currently be purchased for approximately $2.98.

How big of a company is Nymox Pharmaceutical?

Nymox Pharmaceutical has a market capitalization of $208.51 million and generates $300,000.00 in revenue each year. View Additional Information About Nymox Pharmaceutical.

What is Nymox Pharmaceutical's official website?

The official website for Nymox Pharmaceutical is http://www.nymox.com/.

How can I contact Nymox Pharmaceutical?

Nymox Pharmaceutical's mailing address is 9900 CAVENDISH BLVD. SUITE 306, ST. LAURENT A8, H4M 2V2. The biopharmaceutical company can be reached via phone at 800-936-9669 or via email at [email protected]


MarketBeat Community Rating for Nymox Pharmaceutical (NASDAQ NYMX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  137 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about Nymox Pharmaceutical and other stocks. Vote "Outperform" if you believe NYMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NYMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel